Onderzoeker
Cristina PRIETO FERNANDEZ
- Disciplines:Systeembiologie
Affiliaties
- Laboratorium voor Moleculaire Biologie van Leukemie (VIB-KU Leuven) (Afdeling)
Lid
Vanaf1 sep 2017 → 31 mei 2022
Projecten
1 - 1 of 1
- Epigenetische benadering van combinatietherapieën voor ALL.Vanaf1 okt 2018 → 31 mei 2022Financiering: FWO mandaten
Publicaties
1 - 6 van 6
- Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia(2019)
Auteurs: Michaël Broux, Cristina PRIETO FERNANDEZ, Sofie Demeyer, Marlies Vanden Bempt, Inge Lodewijckx, Jan Cools
Pagina's: 1323 - 1336 - GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human Mesoderm(2019)
Auteurs: Julio Castano, Sergi Aranda, Clara Bueno, Fernando J Calero-Nieto, Eva Mejia-Ramirez, Jose Luis Mosquera, Enrique Blanco, Xiaonan Wang, Cristina PRIETO FERNANDEZ, Lorea Zabaleta, et al.
Pagina's: 515 - 529 - Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment(2019)
Auteurs: Rocio G Urdinguio, Virginia Lopez, Gustavo F Bayon, Rafael Diaz de la Guardia, Marta I Sierra, Estela Garcia-Torano, Raul F Perez, Maria G Garcia, Antonella Carella, Patricia C Pruneda, et al.
Pagina's: 5016 - 5037 - Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.(2018)
Auteurs: Cristina PRIETO FERNANDEZ, B López-Millán, H Roca-Ho, RW Stam, D Romero-Moya, FJ Rodríguez-Baena, A Sanjuan-Pla, V Ayllón, M Ramírez, M Bardini, et al.
Pagina's: 2306 - Epigenome-wide analysis reveals specific DNA hypermethylation of T cells during human hematopoietic differentiation(2018)
Auteurs: J Ramon Tejedor, Clara Bueno, Isabel Cobo, Gustavo F Bayon, Cristina PRIETO FERNANDEZ, Cristina Mangas, Raul F Perez, Pablo Santamarina, Rocio G Urdinguio, Pablo Menendez, et al.
Pagina's: 903 - 923 - IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q-AML(2018)
Auteurs: Belen Lopez-Millan, Rafael Diaz de la Guardia, Heleia Roca-Ho, Eduardo Anguita, Abul BMMK Islam, Damia Romero-Moya, Cristina PRIETO FERNANDEZ, Francisco Gutierrez-Aguera, Jose Antonio Bejarano-Garcia, Jose Antonio Perez-Simon, et al.